End-of-day quote
Other stock markets
|
||
- USD | - |
28/03 | Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
28/03 | CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Herb-based Supplements and Hemp-based Cannabidiol
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26/18/26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21/22/21 |
William McCorkle
BRD | Director/Board Member | 56 | 21/22/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,228,469 | 163,197,469 ( 99.98 %) | 0 | 99.98 % |
Stock B | 0 | 1,000 | 0 | 0 |
Company contact information
CV Sciences, Inc.
9530 Padgett Street Suite 107
92126, San Diego
+866 290 2157
http://www.cvsciences.comSector
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- CVSI Stock
- Stock
- Company CannaVEST Corp